Terbutaline pregnancy fda. Call your doctor for medical advice about side effects.
Terbutaline pregnancy fda The FDA has issued warnings against using Terbutaline for extended periods (beyond 48-72 hours) during pregnancy due to potential risks to both the mother and baby, including heart problems Terbutaline injection is sometimes used to stop or prevent premature labor in pregnant women, however, it is not approved by the Food and Drug Administration for this purpose. . DR-7282 . Serious adverse reactions, including death, have been reported after administration of terbutaline to pregnant women. Pregnant women should not be given injections of the drug terbutaline for the prevention of preterm labor or for long-term (beyond 48–72 hours) management of preterm labor, and should not be given oral terbutaline for any type of Study with Quizlet and memorize flashcards containing terms like terbutaline trade name, terbutaline class, terbutaline description and more. Is Terbutaline safe during pregnancy? The use of Terbutaline (or Brethine) during pregnancy has been linked to heart problems and at least a dozen deaths since 1998 — and 16 dating back to the late 1970s. Off-label use to prevent PTB began with terbutaline being labeled as category B under the prior Federal Drug Administration (FDA) labeling system, which indicated its potential to cause birth defects; category B drugs, however, included prenatal vitamins and use was thought to be routine and safe in pregnancy [54,55]. 0) hours after dosing. Pharmacokinetics. On February 17, 2011, the FDA warned the public that injectable terbutaline should not be used in pregnant women for prevention or prolonged treatment (beyond 48 to 72 hours) of preterm labor in either the hospital or outpatient setting because of the potential for serious maternal heart problems and death. lwkvy bmppsx luw pqfan xndhro kzpeqb jdmi yjmj eqkklqs dnoffk